Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Apr 21;11(1):10.
doi: 10.1186/s13395-021-00266-5.

Severe acute myopathy following SARS-CoV-2 infection: a case report and review of recent literature

Affiliations
Review

Severe acute myopathy following SARS-CoV-2 infection: a case report and review of recent literature

Badrul Islam et al. Skelet Muscle. .

Abstract

Background: SARS-CoV2 virus could be potentially myopathic. Serum creatinine phosphokinase (CPK) is frequently found elevated in severe SARS-CoV2 infection, which indicates skeletal muscle damage precipitating limb weakness or even ventilatory failure.

Case presentation: We addressed such a patient in his forties presented with features of severe SARS-CoV2 pneumonia and high serum CPK. He developed severe sepsis and acute respiratory distress syndrome (ARDS) and received intravenous high dose corticosteroid and tocilizumab to counter SARS-CoV2 associated cytokine surge. After 10 days of mechanical ventilation (MV), weaning was unsuccessful albeit apparently clear lung fields, having additionally severe and symmetric limb muscle weakness. Ancillary investigations in addition with serum CPK, including electromyogram, muscle biopsy, and muscle magnetic resonance imaging (MRI) suggested acute myopathy possibly due to skeletal myositis.

Conclusion: We wish to stress that myopathogenic medication in SARS-CoV2 pneumonia should be used with caution. Additionally, serum CPK could be a potential marker to predict respiratory failure in SARS-CoV2 pneumonia as skeletal myopathy affecting chest muscles may contribute ventilatory failure on top of oxygenation failure due to SARS-CoV2 pneumonia.

Keywords: Electromyogram; Guillain-Barré syndrome; Myopathy; Nerve conduction; SARS-CoV2.

PubMed Disclaimer

Conflict of interest statement

No authors have financial, professional, or personal conflict of interest that may influence this manuscript to disclose.

Figures

Fig. 1
Fig. 1
Nerve conduction study, electromyogram, and disease trajectory. (a) Motor and sensory nerve conduction was normal despite severe muscle weakness. Compound muscle action potential (CMAP) amplitudes are measured in millivolts (mV); 2 mV per division for all motor study traces. DML, distal motor latency in ms. MCV1, motor conduction velocity in millisecond (ms). MCV2, motor conduction velocity in ms. Sensory nerve action potential (SNAP) amplitudes are measured in microvolts (μV); 20 μV per division for all sensory study traces. DSL, distal sensory latency. SCV, sensory conduction velocity. (b) Electromyogram (EMG) showing myopathic motor unit potentials, a full recruitment pattern and spontaneous muscle fiber activity in several sampled muscles. Motor unit potential (MUP) amplitudes are measured in microvolt (μV); 200 μV per division for all EMG traces
Fig. 2
Fig. 2
Muscle histopathology and MRI of upper thigh axial sections. (a-d) Muscle histopathology sections sampled from quadriceps femoris muscle stained with hematoxylin and eosin, showed variation in muscle fiber size with predominantly spherical shape myosites and multifocal and discrete myosite degeneration lacking infiltration of inflammatory cells. (e) T2 weighted MRI section of the upper thigh done on day 20, showed marked hyperintensity in both the quadriceps muscles. (f) Repeat T2-weighted MRI of the same section of the thigh muscles done after 48 days of the 1st MRI shows both the quadriceps muscles appear normal

Similar articles

  • Severe Covid-19.
    Berlin DA, Gulick RM, Martinez FJ. Berlin DA, et al. N Engl J Med. 2020 Dec 17;383(25):2451-2460. doi: 10.1056/NEJMcp2009575. Epub 2020 May 15. N Engl J Med. 2020. PMID: 32412710 Review. No abstract available.
  • A Patient with Fever and Dyspnea.
    Matias WR, Vaidya A, Brigl M, Bebell LM. Matias WR, et al. N Engl J Med. 2020 Nov 5;383(19):e111. doi: 10.1056/NEJMimc2019378. N Engl J Med. 2020. PMID: 33211933 No abstract available.
  • Severe COVID-19 Infections-Knowledge Gained and Remaining Questions.
    Bos LDJ, Brodie D, Calfee CS. Bos LDJ, et al. JAMA Intern Med. 2021 Jan 1;181(1):9-11. doi: 10.1001/jamainternmed.2020.6047. JAMA Intern Med. 2021. PMID: 32945833 No abstract available.
  • Neuromuscular involvement in COVID-19 critically ill patients.
    Cabañes-Martínez L, Villadóniga M, González-Rodríguez L, Araque L, Díaz-Cid A, Ruz-Caracuel I, Pian H, Sánchez-Alonso S, Fanjul S, Del Álamo M, Regidor I. Cabañes-Martínez L, et al. Clin Neurophysiol. 2020 Dec;131(12):2809-2816. doi: 10.1016/j.clinph.2020.09.017. Epub 2020 Oct 15. Clin Neurophysiol. 2020. PMID: 33137571 Free PMC article.
  • Treatment of COVID-19: a review of current and prospective pharmacotherapies.
    Quek E, Tahir H, Kumar P, Hastings R, Jha R. Quek E, et al. Br J Hosp Med (Lond). 2021 Mar 2;82(3):1-9. doi: 10.12968/hmed.2021.0112. Epub 2021 Mar 12. Br J Hosp Med (Lond). 2021. PMID: 33792391 Review.

Cited by

References

    1. Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, Chang J, Hong C, Zhou Y, Wang D, Miao X, Li Y, Hu B. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA neurology. 2020;77(6):683–690. doi: 10.1001/jamaneurol.2020.1127. - DOI - PMC - PubMed
    1. Guidon AC, Amato AA. COVID-19 and neuromuscular disorders. Neurology. 2020;94(22):959–969. doi: 10.1212/WNL.0000000000009566. - DOI - PubMed
    1. Madia F, Merico B, Primiano G, Cutuli SL, De Pascale G, Servidei S. Acute myopathic quadriplegia in patients with COVID-19 in the intensive care unit. Neurology. 2020;95(11):492–494. doi: 10.1212/WNL.0000000000010280. - DOI - PubMed
    1. Leung TW, Wong KS, Hui AC, To KF, Lai ST, Ng WF, Ng HK. Myopathic changes associated with severe acute respiratory syndrome: a postmortem case series. Archiv Neurol. 2005;62(7):1113–7. doi: 10.1001/archneur.62.7.1113. - DOI - PubMed
    1. Tsai LK, Hsieh ST, Chao CCm, Chen YC, Lin YH, Chang SC, Chang YC Neuromuscular disorders in severe acute respiratory syndrome. Archives of neurology 2004; 61(11): 1669-1673, DOI: 10.1001/archneur.61.11.1669. - PubMed

MeSH terms